Field Medical Value Lead
Bayer
Summary
The Field Medical Value Lead will lead Bayer's integrated US medical-value engagement strategy, connecting clinical, health-economic and real-world evidence with the needs of health systems and health payers. Lead both the Medical Account Director (MAD) team and the Field Health Economics & Outcomes Research (HEOR) team, enabling credible scientific partnerships, appropriate evidence-informed access and improved population-health decision making across the product lifecycle. Preserve the independence, scientific integrity and nonpromotional character of the medical function.
Job description
Your Tasks and Responsibilities
Integrated Medical-Value Strategy
- Set an integrated national strategy and operating priorities for both teams, aligned with US Medical, therapeutic-area and HEOR strategy.
- Translate evolving clinical, economic and population-health needs into differentiated health-system and payer engagement plans.
- Define a shared scientific agenda without erasing the teams' distinct expertise or customer responsibilities, and adapt priorities across development, launch and established-product stages.
People Leadership and Capability Development
- Lead, coach and develop both reporting teams, with clear objectives, role ownership and expectations for scientific quality and collaboration.
- Build capability through field coaching, joint customer visits, structured feedback and clinical/economic evidence training.
- Lead talent selection, development and succession planning within HR processes.
- Apply Visionary, Architect, Catalyst and Coach behaviors by setting direction, designing effective ways of working, removing barriers and growing others' judgment.
Strategic Customer Partnerships and Account Planning
- Guide long-term scientific relationships with health-system and payer medical, pharmacy and population-health leaders.
- Set standards for account insight, stakeholder mapping and medical outcomes planning, reflecting formulary, utilization-management and care-delivery processes.
- Support complex engagements and ensure coordinated execution by MADs and Field HEOR, with MSL and Medical Director involvement where appropriate.
- Resolve overlapping coverage through explicit ownership and purposeful collaboration.
Coverage, Priorities and Resource Stewardship
- Prioritize account coverage, deployment and customer engagement using scientific need, evidence readiness, strategic relevance and team capacity.
- Allocate work and manage approved resources and expenditure within delegated authority, making trade-offs transparent and escalating unmet needs.
- Align national priorities with regional realities and sustained field presence.
- Maintain an adaptable operating model that reduces duplication and protects time for high-value scientific work.
Evidence Insights and Research Partnership
- Establish a systematic process to synthesize customer insights, evidence gaps and emerging population-health priorities across both teams.
- Partner with HEOR Research Strategy and therapeutic-area researchers to inform evidence priorities and feasible collaborations, including real-world evidence (RWE), retrospective database analyses, burden-of-illness studies and economic modeling.
- Guide field input and customer relevance; retain study design, funding, approval and execution responsibilities within established research governance.
Scientific and Economic Communication Excellence
- Ensure balanced, accurate and audience-appropriate interpretation of clinical, epidemiologic and economic evidence.
- Set expectations for communicating model assumptions, uncertainty and population applicability, including budget-impact and cost-effectiveness models.
- Strengthen team readiness for scientific education and unsolicited questions through approved processes.
- Maintain standards for evidence quality, methodological understanding and medical account planning rather than substituting promotional messages for scientific exchange.
Matrix Alignment and Lifecycle Readiness
- Align engagement, evidence education and launch readiness with US Medical, HEOR, Market Access and relevant therapeutic-area partners.
- Coordinate with Medical Science Liaisons (MSLs), Medical Directors and national account/customer-engagement colleagues to translate national priorities into coherent customer support.
- Bring external scientific, congress and competitive HEOR/RWE insights into planning while maintaining distinct Medical and Commercial accountabilities and appropriate information-sharing boundaries.
Governance, Impact and Continuous Improvement
- Embed FDA/OIG requirements, company policies and research governance in the operating model, with timely escalation of scientific, compliance and resource risks.
- Establish meaningful measures of scientific engagement quality, team capability, evidence-insight usefulness and execution.
- Review progress with partners, act on feedback and improve ways of working.
Key Relationships
Internally, partner with US Medical leadership, therapeutic-area Medical Directors, MSL leadership, HEOR Research Strategy, Market Access, national account/customer-engagement teams, Health Systems marketing/support, Compliance, Legal and HR. Externally, engage senior clinical, pharmacy, economic and population-health stakeholders across health systems, IDNs, ACOs, health plans, payers and PBMs. Build trust through scientific credibility and responsiveness, coordinating cross-functional involvement without compromising Medical independence.
Leadership Accountability and Decision Rights
Within approved strategy and delegated authority, the Lead sets team priorities, coverage recommendations, account-planning standards, coaching expectations and resource allocation. MADs and Field HEOR retain day-to-day scientific account engagement and execution within their respective roles. Research priorities are developed jointly with HEOR Research Strategy and Medical; protocols, methods, study funding and approvals remain with the designated governance owners. Hiring, organizational changes and expenditure beyond delegated limits require the relevant approvals. Pricing, contracting and rebate negotiations remain with Market Access/Commercial, and customer coverage or formulary decisions remain with the customer.
Who You Are
Bayer seeks an incumbent who possesses the following:
Required Qualifications
- PhD in HEOR, epidemiology, public health or a relevant quantitative discipline, or PharmD/MD with formal HEOR training.
- Demonstrated expertise in HEOR methods, study design, statistics, RWE and economic modeling, with the ability to critically assess and communicate evidence, assumptions and limitations.
- Substantive experience in HEOR, Medical Affairs or Market Access that includes payer-facing scientific engagement and understanding of US health-system and payer decision frameworks.
- Demonstrated people leadership, coaching and talent development, together with strategic leadership of complex, cross-functional scientific initiatives.
- Ability to integrate health-system and payer perspectives, prioritize resources and influence senior stakeholders while protecting Medical independence.
- Strong scientific communication, analytic judgment and program-management skills; working knowledge of applicable FDA/OIG requirements and compliant scientific exchange.
- Ability to undertake the agreed national customer-engagement and leadership travel.
Preferred
- Experience leading geographically distributed scientific teams or complementary Medical and HEOR capabilities; established relationships with payer and organized health-system decision makers; and a record of research/modeling collaborations that translated customer needs into useful evidence.
- Experience with national account planning, launch readiness, capability building and organizational change in a pharmaceutical or similarly regulated environment.
Requirements
- PhD in HEOR, epidemiology, public health or a relevant quantitative discipline, or PharmD/MD with formal HEOR training
- Demonstrated expertise in HEOR methods, study design, statistics, RWE and economic modeling
- Ability to critically assess and communicate evidence, assumptions and limitations
- Substantive experience in HEOR, Medical Affairs or Market Access including payer-facing scientific engagement
- Understanding of US health-system and payer decision frameworks
- Demonstrated people leadership, coaching and talent development
- Strategic leadership of complex, cross-functional scientific initiatives
- Ability to integrate health-system and payer perspectives and prioritize resources
- Ability to influence senior stakeholders while protecting Medical independence
- Strong scientific communication, analytic judgment and program-management skills
- Working knowledge of applicable FDA/OIG requirements and compliant scientific exchange
- Ability to undertake national customer-engagement and leadership travel
Benefits
- Health care
- Vision
- Dental
- Retirement
- PTO
- Sick leave
- Bonus or commission
Company overview
Bayer AG is a global life science company with core competencies in healthcare and agriculture, operating as one of the world's leading pharmaceutical corporations. Founded in 1863 and headquartered in Leverkusen, Germany, Bayer operates through three primary divisions: Pharmaceuticals, Consumer Health, and Crop Science. The company's pharmaceutical segment focuses on prescription products for cardiology, women's healthcare, oncology, hematology, and ophthalmology, with blockbuster drugs including Xarelto, Eylea, and Nubeqa. Bayer's Consumer Health division markets well-known over-the-counter brands such as Aspirin, Aleve, Claritin, and Bepanthen. The Crop Science division, strengthened by the acquisition of Monsanto, provides seeds, crop protection products, and digital farming solutions. With approximately 92,815 employees worldwide and operations in 80 countries, Bayer is committed to its mission of "Health for all, Hunger for none," driving innovation in medical treatments, agricultural productivity, and sustainable development. The company maintains a strong research and development pipeline, investing heavily in areas like precision medicine, artificial intelligence applications in healthcare, and sustainable agricultural technologies.